Mia Arnhult
Born 1969
Director since 2010 Chair of the Board since 2021
Degree in business economics and trade law, Lund University.
Other important offices:
Director of M2 Asset Management AB and Chair of the Board of Lidingöloppet.
Previous positions:
Auditor at Lindebergs Grant Thornton AB, Controller and CFO at M2 Gruppen and Corem Property Group AB and CEO of M2 Asset Management. Board member of Odd Molly International, Bactiguard Holding, Footway Group and Nanexa.
Shares: 1,200 Company shares and 4,035,000 through related parties.
Independent of the Company and company management, not independent of the Company’s major shareholders.
Lars Höckenström
Born 1956
Board Member since 2016
M.Sc. in Business and Economics, Stockholm University.
Other important offices:
Director of Guard Therapeutics AB (publ) and AB Consiliario.
Previous positions:
Co-founder and Partner, Aragon FK AB, Analyst at Öhman FK AB and Pareto Securities AB, Analyst and Portfolio Manager at Catella Kapitalförvaltning AB, Co-founder and Senior Advisor at Naventus Corporate Finance AB.
Shares: 120,510 Company shares and 300 through related parties.
Independent of the Company and company management, not independent of the Company’s major shareholders.
Fredrik Dahl
Born 1977
Board member since 2021
PhD in molecular medicine, Uppsala University, postdoctoral studies at Stanford Genome Technology Center, Stanford University.
Other important offices:
Chair of the Board of Pixelgen Technologies AB, board member of Mindforce Game Lab AB, Nucleus Capital AB and Colibri Ventures AB.
Previous positions:
Co-Founder and CTO of Vanadis Diagnostics AB and Halo Genomics AB.
Shares: 34,150 Company shares.
Independent of the Company and company management, and independent of the Company's major shareholders.
Pia Gideon
Born 1954
Board member since 2021
M.Sc. in Business and Economics, Stockholm School of Economics.
Other important offices:
Chair of the Board of Directors of Qlucore AB, Director of Apoteket AB and Gideon Partners AB.
Previous positions:
Chair of the Board of Directors of Action Aid AB, Klövern AB and Simris Alg AB, Board member of Metria AB, Min Doktor AB, Guards Therapeutics AB and Proact AB.
Shares: 2,450 Company shares.
Independent of the Company and company management, and independent of the Company's major shareholders.
Thomas Eklund
Born in 1967
Board member since 2024
Bachelor of Economics and MBA, Stockholm School of Economics.
Other important offices:
Board member in Boule Diagnostics AB, Immedica Pharma Holding AB, Surgical Science Sweden AB and Swedencare AB (publ) as well as board member in smaller subsidiaries of these companies or smaller family companies.
Previous positions:
CEO of Investor Growth Capital (now Patricia Industries) during the years 2002–2012, board member in life science companies such as Swedish Orphan International AB (chairman), Carmel Pharma AB, Mabtech Group Holding AB and Mabtech Holding AB.
Shares: 107,605 Company shares and 1,000 through related parties.
Independent of the Company and company management, and independent of the Company's major shareholders.